Vaccine Trials Initiated in Brazil and South Africa

June 30, 2020

Vaccine Trials Initiated in Brazil and South Africa

Trials to assess the COVID-19 vaccine candidate, ChAdOx1 nCoV-19 (AZD1222), developed by the University of Oxford and licensed to AstraZeneca have kicked off in South Africa and Brazil. Trial participants include 2,000 health workers in Sao Paulo and 1,000 people in Rio de Janeiro. The trial will be South Africa’s first for coronavirus. Yourway has an advanced global depot network, with hubs in Sao Paulo and Johannesburg.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Global Clinical Supplies Group (GCSG)

October 14-16, 2025
Hungary, Budapest

Schedule a Meeting

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Schedule a Meeting

Media

Articles

Keeping trials on track: Prioritizing communication in decentralized trials

Open chat

Hello! How can I help you?